Albert David Limited (NSE:ALBERTDAVD)
India · Delayed Price · Currency is INR 842.30
-7.70 (-0.91%)
Sep 11, 2026, 12:30 PM IST
Albert David Market Cap
Albert David has a market cap or net worth of 4.88 billion as of September 10, 2026. Its market cap has increased by 6.32% in one year.
Market Cap
4.88B
Enterprise Value
2.60B
Revenue
3.64B
Ranking
n/a
PE Ratio
21.62
Stock Price
842.30
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.88B, an increase of 5,962.41%. That is a compound annual growth rate of 17.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.88B | 15.51% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.52B |
| Sigachi Industries | 13.26B |
| Anlon Healthcare | 8.65B |
| Amanta Healthcare | 7.84B |
| Bafna Pharmaceuticals | 7.28B |
| Valiant Laboratories | 6.51B |
| Nectar Lifesciences | 2.36B |
| Brooks Laboratories | 1.86B |